Robert Azelby Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Robert Azelby.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Robert Azelby. Robert Azelby is a Director in IMMUNOMEDICS INC ($IMMU) and a Director in Cascadian Therapeutics, Inc. ($CASC) and a President and CEO in ALDER BIOPHARMACEUTICALS INC ($ALDR) and a Director in Clovis Oncology, Inc. ($CLVS) and a EVP & Chief Commercial Officer in Juno Therapeutics, Inc. ($JUNO) and a See Remarks in Juno Therapeutics, Inc. ($JUNO).

Address: 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE 98109 WA

Companies in which Robert Azelby is an Insider

ALDER BIOPHARMACEUTICALS INC

Trading Symbol: ALDR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert Azelby: President and CEO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 24 2019
$ALDR Market Capitalization: $1.19B
$ALDR Previous Close: $23.20

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Cascadian Therapeutics, Inc.

Trading Symbol: CASC
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Robert Azelby: Director
Holdings: 0 shares
Latest Transaction: Mar 13 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Clovis Oncology, Inc.

Trading Symbol: CLVS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert Azelby: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 11 2021
$CLVS Market Capitalization: $2.45B
$CLVS Previous Close: $60.00

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

IMMUNOMEDICS INC

Trading Symbol: IMMU
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Robert Azelby: Director
Holdings: 3,718 shares
Current Value: $15,727
Latest Transaction: Jun 22 2020
$IMMU Market Capitalization: $442.84M
$IMMU Previous Close: $4.23

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Juno Therapeutics, Inc.

Trading Symbol: JUNO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Robert Azelby: EVP & Chief Commercial Officer, See Remarks
Holdings: 82,112 shares
Current Value: $1,704,645
Latest Transaction: Mar 07 2018
$JUNO Market Capitalization: $2.09B
$JUNO Previous Close: $20.76

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Robert Azelby

Sentiment: All, ALDR, CASC, CLVS, IMMU, JUNO

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 11 2021CLVSClovis Oncology, I ...Azelby RobertDirectorOption ExerciseA5.9742,223252,07142,223
Jun 22 2020IMMUIMMUNOMEDICS INCAzelby RobertDirectorOption ExerciseA33.626,540219,8756,540
Jun 22 2020IMMUIMMUNOMEDICS INCAzelby RobertDirectorGrantA0.003,71803,7180 to 3.7 K
Jun 05 2020CLVSClovis Oncology, I ...Azelby RobertDirectorOption ExerciseA6.4840,138260,09440,138
Feb 27 2020IMMUIMMUNOMEDICS INCAzelby RobertDirectorOption ExerciseA16.3622,500368,10022,500
Oct 24 2019ALDRALDER BIOPHARMACEU ...Azelby RobertPresident and CEOOption ExerciseD16.20150,0002,430,0000
Oct 24 2019ALDRALDER BIOPHARMACEU ...Azelby RobertPresident and CEOOption ExerciseD0.0015,00000

View all Robert Azelby insider transactions.